Compound information
- Natural Products
- ZC847552
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-3,3-dimethyl-butanoic acid
- InChI
- InChI=1S/C14H19NO4/c1-14(2,3)11(12(16)17)15-13(18)19-9-10-7-5-4-6-8-10/h4-8,11H,9H2,1-3H3,(H,15,18)(H,16,17)/t11-/m1/s1
- InChI Key
- NSVNKQLSGGKNKB-LLVKDONJSA-N
- SMILES
- CC(C)(C)[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000000392028
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.701 |
LogS | -3.017 | LogD | 1.888 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.015 | Pgp substrate | 0.002 |
HIA | 0.242 | F20 % | 0.991 |
F30 % | 0.977 | Caco-2 | -5.141 |
MDCK | -5.116 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.258 | PPB | 87.336 |
VD | 0.561 | Fu | 0.892 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.637 |
CYP2A6 substrate | 0.431 | CYP2B6 substrate | 0.641 |
CYP2C19 inhibitor | 0.059 | CYP2C19 substrate | 0.883 |
CYP2C8 substrate | 0.763 | CYP2C9 inhibitor | 0.091 |
CYP2C9 substrate | 0.503 | CYP2D6 inhibitor | 0.04 |
CYP2D6 substrate | 0.532 | CYP2E1 substrate | 0.351 |
CYP3A4 inhibitor | 0.007 | CYP3A4 substrate | 0.529 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.752 | CL | 5.415 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.001 | Hepatotoxicity | 0.753 |
Mutagenicity | 0.158 | Rat Oral Acute Toxicity | 0.044 |
FDAMDD | 0.254 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.006 |
Eye Irritation | 0.625 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.212 | IGC50 | 2.213 |
LC50FM | 3.668 | LC50DM | 5.156 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.2 | NR-AR-LBD | 0.258 |
NR-AhR | 0.006 | NR-Aromatase | 0.052 |
NR-ER | 0.248 | NR-ER-LBD | 0.399 |
NR-PPAR-gamma | 0.523 | SR-ARE | 0.023 |
SR-ATAD5 | 0.394 | SR-HSE | 0.067 |
SR-MMP | 0.012 | SR-p53 | 0.02 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.